Latest news with #TreatmentTracker
Business Wire
01-05-2025
- Health
- Business Wire
seca Launches mBCA Alpha to Further Integrate Body Composition Screening into Primary Care
NEW YORK--(BUSINESS WIRE)-- seca, the global leader in medical measuring and weighing, today announced the latest addition to its line of advanced body composition analyzers, mBCA Alpha (Alpha), a compact, portable scanner specifically designed for use in a primary care setting. This new product further enhances seca's transformation from a measuring and weighing company to a modern technology-first solutions partner, making body composition screenings more accessible to all providers–not just specialists. Utilizing validated bioelectrical impedance analysis (BIA), Alpha delivers a complete picture of a patient's body composition in just 24 seconds. seca's Alpha will assist providers in monitoring and flagging health measures such as early signs of excess adiposity, age-related muscle decline, and the total body impact of medications such as GLP-1s. The Alpha scanner is powered by the company's proprietary Analytics 125 platform, granting healthcare providers access to cloud-based reporting, seca's Treatment Tracker, and an app for patients that enables real-time data access. Before the launch of a solution tailored to primary care providers, teams were forced to rely on methods like weight and body mass indexing (BMI) to understand their patients' risk for chronic conditions like obesity, diabetes, heart disease, and metabolic syndrome, which been criticized as an outdated, misleading, and even racially biased method of measuring health. Alpha's integration of body composition into primary care allows providers to gather more accurate and previously inaccessible insights into body fat, muscle mass, and visceral fat. This enables care teams to make more data-driven diagnoses, treatment, and long-term health monitoring decisions. 'We are witnessing a clinical transformation as clinicians and patients realize that BMI is no longer enough,' said Nina Crowley, PhD, RD, Director of Clinical Education and Partnerships at seca. 'As the industry shifts toward embracing a longitudinal care model that prioritizes precision, personalization, and prevention, we must ensure teams have innovative solutions that allow them to succeed in the care of their patients. Alpha was built to reflect how today's clinicians work–quickly, accurately, and intuitively.' Alpha and the rest of seca's bioimpedance technology solutions are among the most clinically validated in the world, with 97 percent correlation to a whole-body MRI and 98 percent agreement with the gold-standard 4-compartment model for fat mass. By building its solutions on a foundation of scientific rigor, seca ensures that providers make decisions based on the highest-quality data available. 'As a primary care clinician and obesity medicine specialist, I'm a firm believer in the impact regular body composition screenings can have on patient care,' said Dr. Angela Fitch, Co-Founder and Chief Medical Officer of knownwell, a primary care company that uses seca's body composition scan for patients at its Boston and Dallas clinics. 'Rather than reference an outdated measurement like BMI, enabling patients to access body composition scans at their primary care appointments can help them engage in more meaningful conversations with their clinicians about their health goals and appropriate next steps to achieve them, resulting in better treatment outcomes.' The launch of Alpha follows the company's introduction of Treatment Tracker, an industry-first solution that integrates a patient's treatment plan with their body composition results on a single platform to monitor clinical interventions, visualize changes, and modify treatment plans in real-time. For more information about seca and its suite of body composition solutions transforming care, please visit About seca seca, the global leader in medical body composition and weighing solutions, empowers healthcare providers with advanced technology that goes beyond weight and BMI to support comprehensive obesity care. With over 185 years of German engineering, seca sets the standard for precision, innovation, and reliability in medical measurement. Trusted worldwide in obesity medicine, bariatrics, and metabolic health, seca's scientifically validated body composition analyzers provide clinicians with key insights into fat mass, muscle mass, and hydration—helping optimize patient outcomes. seca's solutions integrate seamlessly into clinical workflows, ensuring accurate, data-driven care.
Yahoo
27-03-2025
- Health
- Yahoo
seca Unveils First-Of-Its-Kind ‘Treatment Tracker' to Directly Link Patient Treatment Plans with Body Composition Data
The Tool Will Enable Health and Wellness Providers to Track Clinical Interventions, Visualize Body Composition Changes, and Adjust Treatment Plans in Real-Time NEW YORK, March 27, 2025--(BUSINESS WIRE)--seca, the global leader in medical measuring and weighing, today announced its newest data-driven solution, Treatment Tracker. This first-of-its-kind solution integrates a patient's treatment plan with their body composition results on a single platform, enabling healthcare providers to monitor clinical interventions, visualize changes, and modify treatment plans in real-time to enhance patient outcomes. Historically, body composition data and treatment plans have been disconnected, forcing care teams to gather information from various sources, such as medical records and body composition reports. This fragmented approach often resulted in delayed or ineffective patient treatment adjustments, leaving them with less-than-ideal outcomes. This launch signifies a major leap forward for seca and the healthcare industry—ensuring body composition analysis is not just measured but actively used to improve care. "As the leader in precision and accuracy measurement, seca recognizes the need for body composition analysis to evolve from just a measurement into a tool that significantly enhances patient outcomes," said Nina Crowley, PhD, RD, Director of Clinical Education and Partnerships at seca. "With the industry shifting away from outdated metrics like body mass index (BMI), it's more important to provide clinicians with accurate measurements for care now than ever. Our Treatment Tracker will help close this gap and create a more interoperable data-backed experience that boosts providers' confidence and patient outcomes." Now, with the seca Treatment Tracker, providers can: Set and track personalized goals for fat mass, muscle mass, and total weight based on evidence-based treatment expectations. Visualize body composition changes in response to interventions such as nutrition, exercise, medications, and surgical treatments—all in one dynamic graph. Adjust treatment plans proactively by monitoring fat-free mass and muscle preservation, ensuring timely modifications to therapy, medication, or lifestyle changes. Engage in shared decision-making, using real-time data to foster trust, motivation, and adherence while collaborating with patients to align care with their goals. Combining treatment planning with body composition analysis, seca's Treatment Tracker provides healthcare providers with essential tools for a more efficient, data-driven approach to patient care. This software will advance care across various specialties and health settings, including obesity medicine, primary care, endocrinology, functional medicine, longevity, and sports performance. "Safe weight loss needs to be a top priority, especially as more individuals are prescribed medications like GLP-1s for various conditions," said Dr. Leslie Golden, Obesity Medicine Physician, CEO, and founder of Weight in Gold Wellness. "With the Treatment Tracker, clinicians prescribing these medications and other treatment plans can follow more closely along in the weight management journey of our patients, rather than jotting down a passive metric in the patient file that we revisit every few months. Adjusting nutrition, exercise, and medication in real-time based on these measures will help us achieve better long-term results for our patients and empower them to take a more active lead in their journey to improved metabolic health." The introduction of the Treatment Tracker marks a significant milestone in seca's journey as the company looks to grow and transition from being a global leader in measurement to becoming a leader in integrated body composition solutions. seca remains dedicated to advancing clinical care with tools and technology that help personalize treatment, monitor progress, and enhance results. For more information about seca and its suite of body composition solutions, please visit, About seca seca, the global leader in medical body composition and weighing solutions, empowers healthcare providers with advanced technology that goes beyond weight and BMI to support comprehensive obesity care. With over 185 years of German engineering, seca sets the standard for precision, innovation, and reliability in medical measurement. Trusted worldwide in obesity medicine, bariatrics, and metabolic health, seca's scientifically validated body composition analyzers provide clinicians with key insights into fat mass, muscle mass, and hydration—helping optimize patient outcomes. seca's solutions integrate seamlessly into clinical workflows, ensuring accurate, data-driven care. View source version on Contacts Media Contact: secaCaroline Rueveseca@ 847-609-4055 Sign in to access your portfolio
